(MARK
ONE)
|
|
||
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
||
For
the quarterly period ended July 3, 2005
or
|
|||
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
||
For
the transition period from
to
|
|
Delaware
(State
or other jurisdiction of incorporation or organization)
|
|
94-2551470
(I.R.S.
Employer Identification Number)
|
|
|
|
|
|
|
|
3975
East Bayshore Road, Palo Alto, California
(Address
of principal executive offices)
|
|
94303
(Zip
Code)
|
|
Page
|
||
PART
I - FINANCIAL INFORMATION
|
||
3 | ||
4 | ||
5 | ||
6
|
||
11
|
||
17
|
||
25
|
||
PART
II - OTHER INFORMATION
|
||
26
|
||
26
|
||
26
|
||
26
|
||
26
|
||
27
|
||
28
|
July
3,
|
December
31,
|
||||||
2005
|
2004
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
7,628
|
$
|
4,547
|
|||
Restricted
cash
|
426
|
686
|
|||||
Accounts
receivable, net of allowance for doubtful accounts of $221
at July 3, 2005
and $292 at December 31, 2004
|
5,772
|
6,186
|
|||||
Inventories,
net
|
7,081
|
8,355
|
|||||
Other
current assets
|
1,337
|
1,757
|
|||||
Total
current assets
|
22,244
|
21,531
|
|||||
Property,
plant and equipment, net
|
18,007
|
21,110
|
|||||
Restricted
cash loans
|
1,020
|
1,149
|
|||||
Other
assets
|
1,134
|
1,157
|
|||||
Total
assets
|
$
|
42,405
|
$
|
44,947
|
|||
LIABILITIES,
REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’
EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Current
portion of long term debt and capital leases
|
$
|
1,280
|
$
|
1,463
|
|||
Line
of credit
|
2,996
|
2,975
|
|||||
Accounts
payable
|
1,984
|
2,544
|
|||||
Accrued
compensation
|
952
|
1,378
|
|||||
Other
accrued liabilities
|
5,940
|
6,643
|
|||||
Total
current liabilities
|
13,152
|
15,003
|
|||||
Term
debt and capital leases
|
9,637
|
11,644
|
|||||
Government
grants advance
|
426
|
505
|
|||||
Other
long term liabilities
|
2,947
|
3,222
|
|||||
Total
liabilities
|
26,162
|
30,374
|
|||||
Commitments
and contingencies (Note 5)
|
|||||||
Series
A 10% cumulative preferred stock, $0.001 par value; $1.00 stated
value;
5,000 shares authorized, 4,810 shares outstanding (Liquidation
preference $4,893)
|
4,810
|
4,810
|
|||||
Stockholders’
equity:
|
|||||||
Common
stock, $0.001 par value per share; 50,000 shares authorized,
26,788 shares
and 26,488 shares outstanding at July 3, 2005 and December
31, 2004,
respectively
|
27
|
26
|
|||||
Capital
in excess of par value
|
78,072
|
77,957
|
|||||
Accumulated
other comprehensive income:
|
|||||||
Cumulated
translation adjustment
|
2,818
|
4,358
|
|||||
Accumulated
deficit
|
(69,484
|
)
|
(72,578
|
)
|
|||
Total
stockholders’ equity
|
11,433
|
9,763
|
|||||
Total
liabilities, redeemable preferred stock and stockholders’ equity
|
$
|
42,405
|
$
|
44,947
|
Three
months ended
|
Six
months ended
|
||||||||||||
July
3,
|
June
27,
|
July
3,
|
June
27,
|
||||||||||
|
2005
|
2004
|
2005
|
2004
|
|||||||||
Net
revenues
|
$
|
15,172
|
$
|
14,548
|
$
|
30,819
|
$
|
25,615
|
|||||
Cost
of revenues
|
9,788
|
8,936
|
21,058
|
17,402
|
|||||||||
Gross
profit
|
5,384
|
5,612
|
9,761
|
8,213
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development
|
1,017
|
771
|
1,713
|
1,581
|
|||||||||
Selling,
general and administrative
|
2,331
|
2,520
|
4,357
|
5,583
|
|||||||||
Impairment
recoveries for long-lived assets
|
-
|
(1,428
|
)
|
(170
|
)
|
(1,428
|
)
|
||||||
Total
operating expenses
|
3,348
|
1,863
|
5,900
|
5,736
|
|||||||||
Income
from operations
|
2,036
|
3,749
|
3,861
|
2,477
|
|||||||||
Interest
expense, net
|
(297
|
)
|
(635
|
)
|
(568
|
)
|
(1,240
|
)
|
|||||
Cost
of warrants issued
|
-
|
(1,473
|
)
|
-
|
(6,291
|
)
|
|||||||
Other
income (expenses), net
|
(159
|
)
|
(112
|
)
|
133
|
248
|
|||||||
Income
(loss) before provision for income taxes
|
1,580
|
1,529
|
3,426
|
(4,806
|
)
|
||||||||
Provision
for income taxes
|
185
|
343
|
332
|
698
|
|||||||||
Net
income (loss)
|
1,395
|
1,186
|
3,094
|
(5,504
|
)
|
||||||||
Deemed
dividend on redeemable preferred stock
|
120
|
-
|
243
|
-
|
|||||||||
|
|||||||||||||
Net
income (loss) attributable to common stockholders
|
$
|
1,275
|
$
|
1,186
|
$
|
2,851
|
$
|
(5,504
|
)
|
||||
Net
income (loss) per share:
|
|||||||||||||
Basic
|
$
|
0.05
|
$
|
0.09
|
$
|
0.11
|
$
|
(0.44
|
)
|
||||
Diluted
|
$
|
0.04
|
$
|
0.04
|
$
|
0.09
|
$
|
(0.44
|
)
|
||||
Shares
used in computing net income (loss) per share:
|
|||||||||||||
Basic
|
26,782
|
12,548
|
26,697
|
12,548
|
|||||||||
Diluted
|
33,094
|
31,416
|
33,138
|
12,548
|
Six
months ended
|
|||||||
July
3,
|
|
June
27,
|
|
||||
|
|
2005
|
|
2004
|
|||
Cash
flows from operating activities:
|
|||||||
Net
income (loss)
|
$
|
3,094
|
$
|
(5,504
|
)
|
||
Adjustments
to reconcile net income (loss) to net cash provided by (used
in)operating activities:
|
|||||||
Impairment
recoveries from long-lived assets
|
(170
|
)
|
(1,428
|
)
|
|||
Depreciation
and amortization
|
1,134
|
1,218
|
|||||
Charges
related to warrants issued to investors and creditors
|
-
|
6,291
|
|||||
Amortization
of debt issuance costs
|
-
|
59
|
|||||
Unamortized
debt discount
|
-
|
116
|
|||||
Stock
compensation
|
45
|
-
|
|||||
Change
in assets and liabilities:
|
|||||||
Deferred
revenues
|
(17
|
)
|
-
|
||||
Accounts
receivable, net
|
246
|
1,381
|
|||||
Inventories,
net
|
1,274
|
159
|
|||||
Other
current and non current assets
|
443
|
(1,316
|
)
|
||||
Accounts
payable and accrued liabilities
|
(1,850
|
)
|
(2,556
|
)
|
|||
Net
cash provided by (used in) operating activities
|
4,199
|
(1,580
|
)
|
||||
Cash
flows from investing activities:
|
|||||||
Restricted
cash
|
237
|
147
|
|||||
Proceeds
from sale of property, plant and equipment
|
170
|
1,180
|
|||||
Expenditures
for property, plant and equipment
|
(406
|
)
|
(512
|
)
|
|||
Net
cash provided by investing activities
|
1
|
815
|
|||||
Cash
flows from financing activities:
|
|||||||
Repayments
under capital lease
|
(5
|
)
|
-
|
||||
Proceeds
from exercise of stock options
|
19
|
-
|
|||||
Principal
payment on borrowings
|
(986
|
)
|
(1,600
|
)
|
|||
Payments
on line of credit
|
(2,975
|
)
|
(2,295
|
)
|
|||
Borrowings
on line of credit
|
2,996
|
-
|
|||||
Proceeds
from sale of convertible promissory notes
|
-
|
4,500
|
|||||
Investment
credit in Germany
|
(22
|
)
|
-
|
||||
Net
cash provided by (used in) financing activities
|
(973
|
)
|
605
|
||||
Effect
of foreign exchange rate changes on cash
|
(146
|
)
|
433
|
||||
Net
increase in cash and cash equivalents
|
3,081
|
273
|
|||||
Cash
and cash equivalents, beginning of period
|
4,547
|
1,152
|
|||||
Cash
and cash equivalents, end of period
|
$
|
7,628
|
$
|
1,425
|
July
3,
|
|
December
31,
|
|
||||
|
|
2005
|
|
2004
|
|||
Raw
materials
|
$
|
3,727
|
$
|
4,755
|
|||
Work-in-process
|
1,829
|
2,059
|
|||||
Finished
goods
|
1,525
|
1,541
|
|||||
$
|
7,081
|
$
|
8,355
|
July
3,
|
|
December
31,
|
|
||||
|
|
2005
|
|
2004
|
|||
Liabilities
associated with Settlement Agreement
|
2,354
|
2,354
|
|||||
Deferred
tax liability
|
219
|
397
|
|||||
Long-term
restructuring costs
|
147
|
200
|
|||||
Other
|
227
|
271
|
|||||
$
|
2,947
|
$
|
3,222
|
Three
months ended
|
Six
months ended
|
||||||||||||
July
3,
|
June
27,
|
July
3,
|
June
27,
|
||||||||||
2005
|
2004
|
2005
|
2004
|
||||||||||
Net
income (loss) attributable to common stockholders-basic
|
$
|
1,275
|
$
|
1,186
|
$
|
2,851
|
$
|
(5,504
|
)
|
||||
Add:
Interest expense on convertible promissory notes
|
-
|
147
|
-
|
-
|
|||||||||
Add:
Deemed dividend on redeemable preferred stock
|
120
|
-
|
243
|
-
|
|||||||||
Net
income (loss) attributable to common stockholders-diluted
|
$
|
1,395
|
$
|
1,333
|
$
|
3,094
|
$
|
(5,504
|
)
|
||||
Weighted
average common shares outstanding-basic
|
26,782
|
12,548
|
26,697
|
12,548
|
|||||||||
Dilutive
effect of warrants
|
357
|
14,241
|
357
|
-
|
|||||||||
Dilutive
effect of performance shares
|
-
|
-
|
75
|
-
|
|||||||||
Dilutive
effect of Series A preferred shares
|
4,893
|
4,500
|
4,893
|
-
|
|||||||||
Dilutive
effect of stock options
|
1,062
|
127
|
1,116
|
-
|
|||||||||
Weighted
average common shares outstanding - diluted
|
33,094
|
31,416
|
33,138
|
12,548
|
Three
months ended
|
Six
months ended
|
||||||||||||
July
3,
|
June
27,
|
July
3,
|
June
27,
|
||||||||||
2005
|
2004
|
2005
|
2004
|
||||||||||
Automotive
glass
|
$
|
4,937
|
$
|
5,627
|
$
|
11,322
|
$
|
10,028
|
|||||
Electronic
display
|
3,297
|
5,796
|
7,376
|
9,215
|
|||||||||
Window
film
|
5,481
|
1,805
|
9,127
|
3,649
|
|||||||||
Architectural
|
1,457
|
1,320
|
2,994
|
2,723
|
|||||||||
Total
net revenues
|
$
|
15,172
|
$
|
14,548
|
$
|
30,819
|
$
|
25,615
|
Three
months ended
|
Six
months ended
|
||||||||||||
July
3,
|
June
27,
|
July
3,
|
June
27,
|
||||||||||
2005
|
2004
|
2005
|
2004
|
||||||||||
United
States
|
$
|
3,995
|
$
|
2,966
|
$
|
7,711
|
$
|
4,447
|
|||||
Japan
|
2,631
|
5,285
|
6,430
|
8,259
|
|||||||||
France
|
3,170
|
2,471
|
6,493
|
4,719
|
|||||||||
Pacific
Rim
|
3,523
|
1,520
|
6,085
|
3,190
|
|||||||||
Germany
|
1,368
|
1,473
|
2,713
|
2,896
|
|||||||||
Rest
of the world
|
485
|
833
|
1,387
|
2,104
|
|||||||||
Total
net revenues
|
$
|
15,172
|
$
|
14,548
|
$
|
30,819
|
$
|
25,615
|
Three
months ended
|
Six
months ended
|
||||||||||||
July
3,
|
June
27,
|
July
3,
|
June
27,
|
||||||||||
2005
|
2004
|
2005
|
2004
|
||||||||||
Net
income (loss) attributable to common stockholders:
|
|||||||||||||
As
reported
|
$
|
1,275
|
$
|
1,186
|
$
|
2,851
|
$
|
(5,504
|
)
|
||||
Add:
Stock-based employee compensation expense included in reported net
income (loss), net of related tax effects
|
-
|
-
|
45
|
-
|
|||||||||
Deduct:
Total stock-based employee compensation determined under
fair value based
method for all awards, net of related tax
effects
|
(149
|
)
|
(194
|
)
|
(302
|
)
|
(202
|
)
|
|||||
Pro
forma net income (loss) attributable to common
stockholders
|
$
|
1,126
|
$
|
992
|
$
|
2,594
|
$
|
(5,706
|
)
|
||||
Net
income (loss) attributable to common stockholders per
share:
|
|||||||||||||
As
reported - basic
|
$
|
0.05
|
$
|
0.09
|
$
|
0.11
|
$
|
(0.44
|
)
|
||||
Pro
forma - basic
|
$
|
0.04
|
$
|
0.08
|
$
|
0.10
|
$
|
(0.46
|
)
|
||||
As
reported - diluted
|
$
|
0.04
|
$
|
0.04
|
$
|
0.09
|
$
|
(0.44
|
)
|
||||
Pro
forma - diluted
|
$
|
0.04
|
$
|
0.04
|
$
|
0.09
|
$
|
(0.46
|
)
|
Excess
|
|
|||
|
|
Facilities
|
||
Balance
at January 1, 2004
|
$
|
1,569
|
||
Provisions
|
-
|
|||
Adjustment
to reserve
|
(144
|
)
|
||
Cash
payments
|
(569
|
)
|
||
Balance
at June 27, 2004
|
$
|
856
|
Excess
|
|
|||
|
|
Facilities
|
||
Balance
at January 1, 2005
|
$
|
274
|
||
Provisions
|
-
|
|||
Adjustment
to reserve
|
-
|
|||
Cash
payments
|
(21
|
)
|
||
Balance
at July 3, 2005
|
$
|
253
|
Balance
at
|
|
|
|
|
|
Balance
at
|
|
||||||
|
|
December
31,
|
|
|
|
|
|
June
27,
|
|||||
2003
|
Provision
|
Utilized
|
2004
|
||||||||||
Accrued
sales returns and warranty
|
$
|
1,850
|
$
|
578
|
$
|
(434
|
)
|
$
|
1,994
|
|
Balance
at
|
Balance
at
|
|||||||||||
|
December
31,
|
July
3,
|
|||||||||||
2004
|
|
Provision
|
|
Utilized
|
|
2005
|
|||||||
Accrued
sales returns and warranty
|
$
|
2,701
|
$
|
242
|
$
|
(808
|
)
|
$
|
2,135
|
|
|
|
|
|
Greater
|
|||||||||||
|
|
Less
than
|
|
|
Than
|
|||||||||||
|
Total
|
1
Year
|
1-3
Year
|
4-5
Year
|
5
Year
|
|||||||||||
Contractual
Obligations:
|
|
|
|
|
|
|||||||||||
Term
debt (1)
|
$
|
10,879
|
$
|
1,242
|
$
|
2,167
|
$
|
4,782
|
$
|
2,688
|
||||||
Line
of credit
|
2,996
|
2,996
|
--
|
--
|
--
|
|||||||||||
Capital
lease obligations
|
38
|
38
|
--
|
--
|
--
|
|||||||||||
Operating
leases (2)
|
1,981
|
437
|
1,471
|
73
|
--
|
|||||||||||
Total
contractual cash obligations
|
$
|
15,894
|
$
|
4,713
|
$
|
3,638
|
$
|
4,855
|
$
|
2,688
|
(1)
|
Represents
loan agreements with Portfolio Financing Servicing Company, Bank
of
America and Lehman Brothers, and several German
banks.
|
(2)
|
Represents
the remaining rents owed on building we rent in Palo Alto,
California.
|
·
|
our
ability to remain as a going
concern;
|
·
|
our
strategy, future operations and financial plans, including, without
limitation, our plans to install and commercially produce products
on new
machines;
|
·
|
the
success of our restructuring
activities;
|
·
|
the
continued trading of our common stock on the Over-the-Counter
Bulletin
Board;
|
·
|
our
projected need for, and ability to obtain, additional borrowings
and our
future liquidity;
|
·
|
future
applications of thin-film technologies and our development of
new
products;
|
·
|
our
competition;
|
·
|
statements
about the future size of markets;
|
·
|
our
expectations with respect to future grants, investment allowances
and bank
guarantees from the Saxony
government;
|
·
|
our
expected results of operations and cash flows;
|
·
|
pending
and threatened litigation and its outcome; and
|
·
|
our
projected capital expenditures.
|
·
|
fluctuating
customer demand, which is influenced by a number of factors,
including
market acceptance of our products and the products of our customers
and
end-users, changes in product mix, and the timing, cancellation
or delay
of customer orders and shipments;
|
·
|
the
timing of shipments of our products by us and by independent
subcontractors to our customers;
|
·
|
manufacturing
and operational difficulties that may arise due to, among other
things,
quality control, capacity utilization of our production machines,
unscheduled equipment maintenance, and the hiring and training
of
additional staff;
|
·
|
our
ability to introduce new products on a timely basis; and
|
·
|
competition,
including the introduction or announcement of new products by
competitors,
the adoption of competitive technologies by our customers, the
addition of
new production capacity by competitors and competitive pressures
on prices
of our products and those of our customers.
|
·
|
the
development of competing technologies to our anti-reflective
and silver
reflector films for liquid crystal displays in the flat panel
display
industry;
|
·
|
changes
in the way coatings are applied to alternative substrates such
as
tri-acetate cellulose, or TAC;
|
·
|
the
development of new technologies that improve the manufacturing
efficiency
of our competitors;
|
·
|
the
development of new materials that improve the performance of
products that
could compete with our products; and
|
·
|
improvements
in the alternatives to the sputtering technology we use to produce
our
products, such as plasma enhanced chemical vapor deposition,
or PECVD.
|
·
|
difficulty
integrating the purchased operations, technologies, or products;
|
·
|
unanticipated
costs, which would reduce our profitability;
|
·
|
diversion
of management's attention from our core business;
|
·
|
potential
entrance into markets in which we have limited or no prior experience;
and
|
·
|
potential
loss of key employees, particularly those of the acquired business.
|
·
|
delays
in collecting accounts receivable;
|
·
|
higher
manufacturing costs;
|
·
|
additional
warranty and service expenses; and
|
·
|
reduced
or cancelled orders.
|
·
|
unexpected
changes in and the burdens and costs of compliance with a variety
of
foreign laws and regulatory requirements;
|
·
|
potentially
adverse tax consequences; and
|
·
|
global
economic turbulence and political
instability.
|
a.
|
Evaluation
and Disclosure Controls and Procedures.
Under the supervision and with the participation of our management,
including our chief executive officer and acting chief financial
officer,
we conducted an evaluation of the effectiveness of the design
and
operation of our disclosure controls and procedures, as defined
in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of
1934, as
amended, as of July 3, 2005 (the “Evaluation Date”). Based on this
evaluation, our chief executive officer and acting chief financial
officer
concluded as of the Evaluation Date that our disclosure controls
and
procedures were effective such that the information relating
to the
Company, including our consolidated subsidiaries, required to
be disclosed
in our Securities and Exchange Commission ("SEC") reports (i)
is recorded,
processed, summarized and reported with the time periods specified
in SEC
rules and forms, and (ii) is accumulated and communicated to
our
management, including our chief executive officer and acting
chief
financial officer, as appropriate to allow timely decisions regarding
required disclosure.
|
b.
|
Report
on Internal Control Over Financial Reporting.
We will be required by the Sarbanes-Oxley Act to include an assessment
of our internal control over financial reporting and an attestation
from an independent registered public accounting firm in our
Annual Report
on Form 10-K beginning with the filing for our fiscal year ending
December 31, 2006.
|
c.
|
Changes
in Internal Controls.
There were no changes during the quarter ended July 3, 2005 in
our
internal controls over financial reporting that have materially
effected,
or are reasonably likely to materially affect, the internal controls
over
financial reporting.
|
1.
|
Our
stockholders elected William A. Berry, George Boyadjieff, Thomas
G. Hood,
Jami K. Nachtsheim, Joseph B. Reagan and Walter C. Sedgwick as
directors
to serve until the 2006 Annual Meeting of Stockholders and until
their
successors are elected.
|
Director
|
For
|
Withheld
|
William
A. Berry
|
25,326,043
|
36,249
|
George
Boyadjieff
|
25,322,843
|
39,449
|
Thomas
G. Hood
|
25,300,843
|
61,449
|
Jami
K. Nachtsheim
|
25,323,043
|
39,249
|
Joseph
B. Reagan
|
25,208,618
|
153,674
|
Walter
C. Sedgwick
|
25,205,718
|
156,574
|
2.
|
Our
stockholders ratified the selection of Burr, Pilger & Mayer LLP, our
independent registered public accounting firm for the fiscal
year ending
December 31, 2005. On
the matter, there were 25,292,314 votes "FOR", 57,533 votes "AGAINST",
12,445 votes "ABSTAINING", and no broker non-votes.
|
(a)
|
Exhibits
|
Exhibit
|
|
Number
|
Item
|
|
|
Certification
of Principal Executive Officer pursuant to Exchange Act Rules
13a-14 and
15d-14
|
|
|
|
Certification
of Principal Financial Officer pursuant to Exchange Act Rules
13a-14 and
15d-14
|
|
|
|
Certification
of Principal Executive Officer pursuant to 18 U.S.C Section
1350
|
|
|
|
Certification
of Principal Financial Officer pursuant to 18 U.S.C Section
1350
|
Dated:
August 5, 2005
|
|
|
|
|
|
Southwall
Technologies Inc.
|
|
|
|
|
|
|
By:
|
/s/
Thomas G. Hood
|
|
|
|
Thomas
G. Hood
|
|
|
|
President
and Chief Executive Officer
|
|
|
|
|
|
|
By:
|
/s/
Sylvia Kamenski
|
|
|
|
Sylvia
Kamenski
|
|
|
|
Acting
Chief Financial Officer
|